Inspire Investing LLC Buys 112,241 Shares of agilon health, inc. (NYSE:AGL)

Inspire Investing LLC raised its stake in shares of agilon health, inc. (NYSE:AGL) by 106.6% in the 4th quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The fund owned 217,550 shares of the company’s stock after purchasing an additional 112,241 shares during the period. Inspire Investing LLC’s holdings in agilon health were worth $413,000 at the end of the most recent quarter.

Several other large investors have also bought and sold shares of AGL. XTX Topco Ltd bought a new position in agilon health during the 2nd quarter worth $211,000. Ensign Peak Advisors Inc grew its holdings in agilon health by 43.5% during the 2nd quarter. Ensign Peak Advisors Inc now owns 140,937 shares of the company’s stock worth $922,000 after acquiring an additional 42,750 shares during the period. Bank of Montreal Can acquired a new stake in agilon health during the 2nd quarter worth about $404,000. AQR Capital Management LLC grew its holdings in agilon health by 3,338.5% during the 2nd quarter. AQR Capital Management LLC now owns 1,356,438 shares of the company’s stock worth $8,871,000 after acquiring an additional 1,316,990 shares during the period. Finally, The Manufacturers Life Insurance Company grew its holdings in agilon health by 30.1% during the 2nd quarter. The Manufacturers Life Insurance Company now owns 279,143 shares of the company’s stock worth $1,826,000 after acquiring an additional 64,528 shares during the period.

Insiders Place Their Bets

In other news, Director John William Wulf bought 45,000 shares of the company’s stock in a transaction on Thursday, December 5th. The shares were purchased at an average price of $2.18 per share, with a total value of $98,100.00. Following the transaction, the director now directly owns 206,133 shares in the company, valued at $449,369.94. This represents a 27.93 % increase in their ownership of the stock. The purchase was disclosed in a filing with the Securities & Exchange Commission, which is accessible through the SEC website. Also, Director Diana Mckenzie bought 12,500 shares of the company’s stock in a transaction on Monday, November 25th. The shares were purchased at an average cost of $2.28 per share, for a total transaction of $28,500.00. Following the transaction, the director now owns 51,319 shares in the company, valued at approximately $117,007.32. This represents a 32.20 % increase in their ownership of the stock. The disclosure for this purchase can be found here. Insiders have bought a total of 90,000 shares of company stock valued at $198,100 in the last 90 days. 3.20% of the stock is currently owned by corporate insiders.

agilon health Price Performance

AGL stock opened at $3.61 on Friday. The company has a market capitalization of $1.49 billion, a P/E ratio of -3.84 and a beta of 0.53. The company has a debt-to-equity ratio of 0.06, a quick ratio of 1.29 and a current ratio of 1.29. agilon health, inc. has a 52-week low of $1.50 and a 52-week high of $7.73. The business has a 50-day simple moving average of $2.26 and a two-hundred day simple moving average of $3.56.

agilon health (NYSE:AGL) last released its quarterly earnings results on Thursday, November 7th. The company reported ($0.29) earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of ($0.10) by ($0.19). The company had revenue of $1.45 billion for the quarter, compared to analyst estimates of $1.47 billion. agilon health had a negative net margin of 6.88% and a negative return on equity of 47.84%. During the same quarter last year, the firm posted ($0.06) EPS. Research analysts expect that agilon health, inc. will post -0.59 EPS for the current fiscal year.

Analysts Set New Price Targets

AGL has been the subject of a number of recent analyst reports. JMP Securities downgraded agilon health from an “outperform” rating to a “market perform” rating in a report on Monday, November 11th. Citigroup upgraded agilon health from a “sell” rating to a “neutral” rating and increased their price target for the stock from $1.75 to $2.25 in a report on Friday, January 10th. Stifel Nicolaus decreased their price target on agilon health from $7.00 to $2.00 and set a “hold” rating for the company in a report on Tuesday, November 12th. Bank of America downgraded agilon health from a “buy” rating to an “underperform” rating and set a $3.00 target price for the company. in a research note on Wednesday, October 2nd. Finally, William Blair downgraded agilon health from an “outperform” rating to a “market perform” rating in a research note on Friday, November 8th. Two research analysts have rated the stock with a sell rating, fourteen have assigned a hold rating and two have assigned a buy rating to the company’s stock. Based on data from MarketBeat.com, agilon health has an average rating of “Hold” and an average target price of $4.03.

agilon health Profile

agilon health, inc. provides healthcare services for seniors through primary care physicians in the communities of the United States. It offers a platform that manages the total healthcare needs of the patients by subscription-like per-member per-month. The company was formerly known as Agilon Health Topco, Inc and changed its name to agilon health, inc.